(7-methoxy-imidazo[1,2-a]pyridin-3-yl)-(3,4,5-trimethoxyphenyl)methanone

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (7-methoxy-imidazo[1,2-a]pyridin-3-yl)-(3,4,5-trimethoxyphenyl)methanone
• 英文别名: (7-methoxyimidazo[1,2-a]pyridin-3-yl)(3,4,5-trimethoxyphenyl)methanone；(7-methoxy-imidazo[1,2-a]pyridin-3-yl)-(3,4,5-trimethoxy-phenyl)-methanone；(7-Methoxyimidazo[1,2-a]pyridin-3-yl)-(3,4,5-trimethoxyphenyl)methanone
• 化学式: C₁₈H₁₈N₂O₅
• 分子量: 342.351
• InChiKey: AVLMUCCDOHXHGQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  71.3
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4-甲氧基吡啶-2-甲酸甲酯 在 manganese(IV) oxide 、 碳酸氢钠 、 肼 、 三氯氧磷 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 39.33h， 生成 (7-methoxy-imidazo[1,2-a]pyridin-3-yl)-(3,4,5-trimethoxyphenyl)methanone
  参考文献：
  名称：

  Scaffold-Hopping Strategy: Synthesis and Biological Evaluation of 5,6-Fused Bicyclic Heteroaromatics To Identify Orally Bioavailable Anticancer Agents

  摘要：

  Utilizing scaffold-hopping drug-design strategy, we sought to identify a backup drug candidate for BPR0L075 (1), an indole-based anticancer agent. For this purpose, 5,6-fused bicyclic heteroaromatic scaffolds were designed and synthesized through shuffling of the nitrogen from the N-1 position or by insertion of one or two nitrogen atoms into the indole core of 1. Among these, 7-azaindole core 12 showed potent in vitro anticancer activity and improved oral bioavailability (F = 35%) compared with 1 (F < 10%).

  DOI：

  10.1021/jm101027s

文献信息

• Anti-tumor compounds
  申请人：Hsieh Hsing-Pang

  公开号：US20060148801A1

  公开（公告）日：2006-07-06

  Compounds of the following formula: wherein A, D, Q, T, U, V, W, X, Y, Z, R 1 , and ---- are as defined herein. This invention also relates to a method of inhibiting tubulin polymerization, or treating cancer or an angiogenesis-related disorder with one of these compounds.

  以下化合物的结构如下： 其中A、D、Q、T、U、V、W、X、Y、Z、R1和----在此处定义。本发明还涉及一种通过其中一种化合物抑制微管聚合，或治疗癌症或血管生成相关疾病的方法。
• I₂-Catalyzed Three-Component Consecutive Reaction for the Synthesis of 3-Aroylimidazo[1,2-<i>a</i>]-<i>N</i>-Heterocycles
  作者：Yi Zhang、Rener Chen、Zhiming Wang、Lei Wang、Yongmin Ma

  DOI：10.1021/acs.joc.1c00023

  日期：2021.5.7

  A convenient one-pot, three-component reaction has been developed for the synthesis of 3-aroylimidazo[1,2-a]-N-heterocycles from aryl ketones and 2-amino-N-heterocycles using dimethyl sulfoxide as a methylene donor. The reaction proceeds smoothly catalyzed by I2 in the presence of K2S2O8 and affords the desired products in moderate to good yields. This protocol offers significant superiority in accessing

  已经开发了一种方便的一锅三组分反应，用于使用二甲基亚砜作为亚甲基供体，从芳基酮和2-氨基-N-杂环合成3-芳基咪唑并[1,2- a ] -N-杂环。在K 2 S 2 O 8的存在下，反应被I 2平稳催化，并以中等至良好的产率提供所需的产物。该协议在访问具有各种取代方式的生物活性3-芳基咪唑并[1,2- a ] -N-杂环时具有显着优势。
• RING-FUSED HETEROCYCLIC DERIVATIVE
  申请人：Kyowa Hakko Kirin Co., Ltd.

  公开号：EP2671582B1

  公开（公告）日：2016-07-13
• ANTI-TUMOR COMPOUNDS
  申请人：National Health Research Institutes

  公开号：EP1838711A2

  公开（公告）日：2007-10-03
• Tubulin Binding Anti Cancer Agents And Prodrugs Thereof
  申请人：Matteucci Mark

  公开号：US20090042820A1

  公开（公告）日：2009-02-12

  Novel tubulin binding compounds and hypoxia activated prodrugs of novel and known tubulin binding compounds useful for treating cancer and other hyperproliferative diseases are disclosed.